126 related articles for article (PubMed ID: 12658769)
1. Study of the effects of LPS on the TACE gene expression and its function.
Li L; Yang Y; Wang Z; Gong F
J Huazhong Univ Sci Technolog Med Sci; 2002; 22(1):5-8. PubMed ID: 12658769
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the increase of secretion of sTNF alpha induced by lipopolysaccharides and the enhanced expression of TACE mRNA in HL-60 cells and adhesive cells from human spleen.
Ding T; Li L; Zhu K; Huang W; Yang Y
J Tongji Med Univ; 2001; 21(4):265-8, 279. PubMed ID: 12539543
[TBL] [Abstract][Full Text] [Related]
3. [Effect of reduqing on HL-60 cells in secreting tumor necrosis factor alpha production and on TNF alpha converting enzyme mRNA expression].
Wang KF; Li MZ; Yang YZ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Apr; 21(4):283-5. PubMed ID: 12577359
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of three inhibitors of TACE in blocking the converting of pro-TNF alpha into sTNF alpha.
Wang Z; Wang Y; Zhu K; Guo L; Yang Y
J Huazhong Univ Sci Technolog Med Sci; 2003; 23(2):116-20. PubMed ID: 12973924
[TBL] [Abstract][Full Text] [Related]
5. In situ localization of TNFalpha/beta, TACE and TNF receptors TNF-R1 and TNF-R2 in control and LPS-treated lung tissue.
Ermert M; Pantazis C; Duncker HR; Grimminger F; Seeger W; Ermert L
Cytokine; 2003 May; 22(3-4):89-100. PubMed ID: 12849708
[TBL] [Abstract][Full Text] [Related]
6. Expression of tumor necrosis factor-alpha in cultured human endothelial cells stimulated with lipopolysaccharide or interleukin-1alpha.
Imaizumi T; Itaya H; Fujita K; Kudoh D; Kudoh S; Mori K; Fujimoto K; Matsumiya T; Yoshida H; Satoh K
Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):410-5. PubMed ID: 10669637
[TBL] [Abstract][Full Text] [Related]
7. Tumour necrosis factor-alpha converting enzyme (TACE) activity in human colonic epithelial cells.
Kirkegaard T; Pedersen G; Saermark T; Brynskov J
Clin Exp Immunol; 2004 Jan; 135(1):146-53. PubMed ID: 14678276
[TBL] [Abstract][Full Text] [Related]
8. Hypertonicity-enhanced TNF-α release from activated human monocytic THP-1 cells requires ERK activation.
Chou YC; Sheu JR; Chung CL; Hsiao CJ; Hsueh PJ; Hsiao G
Biochim Biophys Acta; 2011 Apr; 1810(4):475-84. PubMed ID: 21256190
[TBL] [Abstract][Full Text] [Related]
9. Increased mRNA expression of tumour necrosis factor-alpha and its converting enzyme in circulating leucocytes of patients with acute myocardial infarction.
Akatsu T; Nakamura M; Satoh M; Hiramori K
Clin Sci (Lond); 2003 Jul; 105(1):39-44. PubMed ID: 12605594
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the role of TNF-α converting enzyme (TACE) in the inhibition of cell surface and soluble TNF-α production by acute ethanol exposure.
von Maltzan K; Tan W; Pruett SB
PLoS One; 2012; 7(2):e29890. PubMed ID: 22319556
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha (TNF-alpha) converting enzyme contributes to production of TNF-alpha in synovial tissues from patients with rheumatoid arthritis.
Ohta S; Harigai M; Tanaka M; Kawaguchi Y; Sugiura T; Takagi K; Fukasawa C; Hara M; Kamatani N
J Rheumatol; 2001 Aug; 28(8):1756-63. PubMed ID: 11508576
[TBL] [Abstract][Full Text] [Related]
12. Expression of tumor necrosis factor-alpha--converting enzyme and tumor necrosis factor-alpha in human myocarditis.
Satoh M; Nakamura M; Satoh H; Saitoh H; Segawa I; Hiramori K
J Am Coll Cardiol; 2000 Oct; 36(4):1288-94. PubMed ID: 11028485
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritis.
Zhang Y; Xu J; Levin J; Hegen M; Li G; Robertshaw H; Brennan F; Cummons T; Clarke D; Vansell N; Nickerson-Nutter C; Barone D; Mohler K; Black R; Skotnicki J; Gibbons J; Feldmann M; Frost P; Larsen G; Lin LL
J Pharmacol Exp Ther; 2004 Apr; 309(1):348-55. PubMed ID: 14718605
[TBL] [Abstract][Full Text] [Related]
14. The regulation of TACE catalytic function by its prodomain.
Li X; Yan Y; Huang W; Yang Y; Wang H; Chang L
Mol Biol Rep; 2009 Apr; 36(4):641-51. PubMed ID: 18386160
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha-converting enzyme and tumor necrosis factor-alpha in human dilated cardiomyopathy.
Satoh M; Nakamura M; Saitoh H; Satoh H; Maesawa C; Segawa I; Tashiro A; Hiramori K
Circulation; 1999 Jun; 99(25):3260-5. PubMed ID: 10385500
[TBL] [Abstract][Full Text] [Related]
16. Activated tumour necrosis factor-alpha shedding process is associated with in-hospital complication in patients with acute myocardial infarction.
Shimoda Y; Satoh M; Nakamura M; Akatsu T; Hiramori K
Clin Sci (Lond); 2005 Apr; 108(4):339-47. PubMed ID: 15603556
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of TNF-alpha processing and TACE-mediated ectodomain shedding by ethanol.
Zhang Z; Cork J; Ye P; Lei D; Schwarzenberger PO; Summer WR; Shellito JE; Nelson S; Kolls JK
J Leukoc Biol; 2000 Jun; 67(6):856-62. PubMed ID: 10857859
[TBL] [Abstract][Full Text] [Related]
18. Unlike for human monocytes after LPS activation, release of TNF-α by THP-1 cells is produced by a TACE catalytically different from constitutive TACE.
Moreira-Tabaka H; Peluso J; Vonesch JL; Hentsch D; Kessler P; Reimund JM; Dumont S; Muller CD
PLoS One; 2012; 7(3):e34184. PubMed ID: 22479555
[TBL] [Abstract][Full Text] [Related]
19. A new method for detecting TNF-alpha-secreting cells using direct-immunofluorescence surface membrane stainings.
Bueno C; Rodriguez-Caballero A; García-Montero A; Pandiella A; Almeida J; Orfao A
J Immunol Methods; 2002 Jun; 264(1-2):77-87. PubMed ID: 12191512
[TBL] [Abstract][Full Text] [Related]
20. Cutting edge: a dominant negative form of TNF-alpha converting enzyme inhibits proTNF and TNFRII secretion.
Solomon KA; Pesti N; Wu G; Newton RC
J Immunol; 1999 Oct; 163(8):4105-8. PubMed ID: 10510344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
